Helios Dominion

Biotech, cybernetics and healthcare — sold as liberation, engineered as dependency, and quietly the Harbingers' most natural ally in the Sphere.

CEO: Rajan Veyra — charismatic futurist who styles himself humanity's guiding light, and means it.

Overview

Helios makes people better. Augmentation, gene work, corrective and elective procedures, and the whole modification market at retail — sold on subscription, financed on flexible terms, and engineered for dependency rather than cure. The branding is utopian and the underbelly is a payment schedule.

It is one of only two majors that builds with tissue while the rest of the Sphere automates, which puts it under far less scrutiny than machine minds attract. Nobody wrote a law about artificial bodies.

Its throne is Helios Crown, the augment capital, and its clinics are on every world that can support one.

What it wants

  • Dominate biotech, cybernetics and healthcare end to end
  • Blur the line between human and machine — from the human side
  • Make its augmentations the entry fee to any profession worth having

The Labour Question

Helios is aligned with the restrictionists, and not for doctrinal reasons.

Its product is human competitiveness. Every augmentation it sells is bought by somebody who needs to keep pace with something — a deadline, a rival, a machine. A cheap and plentiful Instanced workforce destroys that market, because you do not finance a neural upgrade to compete with labour that costs nothing and never sleeps. You simply lose the job.

So Helios funds the ban, quietly and generously.

The alliance nobody remarks on

Helios and the Harbingers are natural allies, which surprises people who assume a transhumanist corporation and a biological-purity religion must be enemies.

They are not. Harbinger doctrine holds that only biological life is real — and an augmented human is still biological. Helios does not make machines into people. It makes people into better people, which is entirely permissible, arguably admirable, and exactly what a movement built on the primacy of biological life should want.

The two have never needed to negotiate. Their interests simply point the same way. See The Arrangement.

Relationships

  • The Harbingers of the Guide — doctrinally compatible, commercially aligned, and no formal relationship whatsoever
  • Novagen Labs — the smaller biotech rival that keeps poaching its senior researchers
  • Weyland Corp — buys Helios augmentation for a workforce that has to keep pace. A customer that would prefer not to be
  • Orion Dynamics — the other beneficiary of the ban, for entirely different reasons

Status

Growing on subscription revenue, praised for its clinics, and holding the restrictionist line for reasons it has never once had to say aloud.